Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

ClinicalTrials.gov ID: NCT04211831

Public ClinicalTrials.gov record NCT04211831. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 2:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Exploratory Phase 2a Study Evaluating the Efficacy and Safety of URO-902 in Subjects With Overactive Bladder and Urge Urinary Incontinence

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the efficacy, safety, and tolerability of a single dose of URO-902 24 milligrams (mg) and 48 mg (administered via intradetrusor injection), compared with placebo, in participants with overactive bladder (OAB) and urge urinary incontinence (UUI) up to 48 weeks post-dose.

Study identification

NCT ID
NCT04211831
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Urovant Sciences GmbH
Industry
Enrollment
80 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 79 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 15, 2019
Primary completion
Nov 17, 2021
Completion
Jul 19, 2022
Last update posted
Apr 19, 2023

2019 – 2022

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Coastal Clinical Research Inc Mobile Alabama 36608
Urological Associates of Southern Arizona Tucson Arizona 85715
Orange County Urology Associates Laguna Hills California 92653
University of Southern California - Norris Hospital Los Angeles California 90033
Tri Valley Urology Medical Group Murrieta California 92562
Stanford University School of Medicine Palo Alto California 94304
Precision Clinical Research LLC Sunrise Florida 33351
Iowa Clinic West Des Moines Iowa 50266
Chesapeake Urology Associates Hanover Maryland 21076
Bay State Clinical Trials Watertown Massachusetts 02472
Beaumont Hospital Royal Oak Michigan 48073
Premier Urology Group, LLC Edison New Jersey 08837
Urology Center of Englewood Englewood New Jersey 07631
Great Lakes Physician PC / Western New York Urology Associates Cheektowaga New York 14225
Accumed Research Associates - ClinEdge - PPDS Garden City New York 11530
Atrium Healthcare Charlotte North Carolina 28203
Urology Specialists of The Carolinas Huntersville North Carolina 28078
Institute For Female Pelvic Medicine Allentown Pennsylvania 18104
Urology of Virginia Virginia Beach Virginia 23462
Washington Urology & Urogynecology Associates Kirkland Washington 98034

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04211831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 19, 2023 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04211831 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →